Jean F. Voltaire

Array ( [id] => 6972312 [patent_doc_number] => 20050038022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Method for treatment of cancer and compositions for use therein' [patent_app_type] => utility [patent_app_number] => 10/472888 [patent_app_country] => US [patent_app_date] => 2002-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8167 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20050038022.pdf [firstpage_image] =>[orig_patent_app_number] => 10472888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6538048 [patent_doc_number] => 20020193408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Method and composition for the treatment of diarrhea and gastrointestinal spasms' [patent_app_type] => new [patent_app_number] => 10/091591 [patent_app_country] => US [patent_app_date] => 2002-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5170 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193408.pdf [firstpage_image] =>[orig_patent_app_number] => 10091591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6112909 [patent_doc_number] => 20020173539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Alpha-pyrone compositions and method for the chemoprevention of cancer' [patent_app_type] => new [patent_app_number] => 10/084391 [patent_app_country] => US [patent_app_date] => 2002-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1950 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20020173539.pdf [firstpage_image] =>[orig_patent_app_number] => 10084391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774676 [patent_doc_number] => 20030018014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Compositions and methods for the treatment of chronic lymphocytic leukemia' [patent_app_type] => new [patent_app_number] => 10/060759 [patent_app_country] => US [patent_app_date] => 2002-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 7960 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20030018014.pdf [firstpage_image] =>[orig_patent_app_number] => 10060759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725560 [patent_doc_number] => 20030207872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'OMEGA-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS' [patent_app_type] => new [patent_app_number] => 10/042226 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27173 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207872.pdf [firstpage_image] =>[orig_patent_app_number] => 10042226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6637377 [patent_doc_number] => 20020086885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Pharmaceutical composition' [patent_app_type] => new [patent_app_number] => 10/036208 [patent_app_country] => US [patent_app_date] => 2001-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9304 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086885.pdf [firstpage_image] =>[orig_patent_app_number] => 10036208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 590318 [patent_doc_number] => 07435755 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-14 [patent_title] => 'CDDO-compounds and combination therapies thereof' [patent_app_type] => utility [patent_app_number] => 09/998009 [patent_app_country] => US [patent_app_date] => 2001-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 46275 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/435/07435755.pdf [firstpage_image] =>[orig_patent_app_number] => 09998009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 121872 [patent_doc_number] => 07709520 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'Diindolylmethane and C-substituted diindolylmethane compositions and methods for the treatment of multiple cancers' [patent_app_type] => utility [patent_app_number] => 09/971152 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 8208 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709520.pdf [firstpage_image] =>[orig_patent_app_number] => 09971152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095736 [patent_doc_number] => 20020052007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives' [patent_app_type] => new [patent_app_number] => 09/957903 [patent_app_country] => US [patent_app_date] => 2001-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15961 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052007.pdf [firstpage_image] =>[orig_patent_app_number] => 09957903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7061645 [patent_doc_number] => 20050004007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Promotion of adoptosis in cancer cells by co-administration of cyclin dependent kinase inhibitiors and cellular differentiation agents' [patent_app_type] => utility [patent_app_number] => 10/363540 [patent_app_country] => US [patent_app_date] => 2001-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15520 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20050004007.pdf [firstpage_image] =>[orig_patent_app_number] => 10363540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6409004 [patent_doc_number] => 20020037929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Method of treating angiogenesis-related disorders' [patent_app_type] => new [patent_app_number] => 09/929381 [patent_app_country] => US [patent_app_date] => 2001-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1590 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037929.pdf [firstpage_image] =>[orig_patent_app_number] => 09929381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711681 [patent_doc_number] => 20030171430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Remedies for cisplatin-tolerant cancer' [patent_app_type] => new [patent_app_number] => 10/344239 [patent_app_country] => US [patent_app_date] => 2003-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3454 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171430.pdf [firstpage_image] =>[orig_patent_app_number] => 10344239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033437 [patent_doc_number] => 20020019372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Use of ascorbic acid and salts of ascorbic acid to promote cell repair and regeneration after injury' [patent_app_type] => new [patent_app_number] => 09/899704 [patent_app_country] => US [patent_app_date] => 2001-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9023 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019372.pdf [firstpage_image] =>[orig_patent_app_number] => 09899704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6921779 [patent_doc_number] => 20010029264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-11 [patent_title] => 'Novel methods and compositions for delivery of taxanes' [patent_app_type] => new [patent_app_number] => 09/795626 [patent_app_country] => US [patent_app_date] => 2001-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10014 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20010029264.pdf [firstpage_image] =>[orig_patent_app_number] => 09795626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6880496 [patent_doc_number] => 20010031783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-18 [patent_title] => 'Alpha-pyrone compositions and method for the chemoprevention of cancer' [patent_app_type] => new [patent_app_number] => 09/792898 [patent_app_country] => US [patent_app_date] => 2001-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1740 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20010031783.pdf [firstpage_image] =>[orig_patent_app_number] => 09792898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8028401 [patent_doc_number] => 08143283 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-03-27 [patent_title] => 'Methods for treating blood-born tumors with thalidomide' [patent_app_type] => utility [patent_app_number] => 09/704054 [patent_app_country] => US [patent_app_date] => 2000-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 6838 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143283.pdf [firstpage_image] =>[orig_patent_app_number] => 09704054 [rel_patent_id] =>[rel_patent_doc_number] =>)